Applied Clinical Trials
Applied Clinical Trials-09-01-2022
Volume: 31
Issue: 9
Applied Clinical Trials-08-01-2022
Volume: 31
Issue: 7/8
Applied Clinical Trials-06-01-2022
Volume: 31
Issue: 6
Applied Clinical Trials-05-01-2022
Volume: 31
Issue: 5
Applied Clinical Trials-04-01-2022
Volume: 31
Issue: 4
Applied Clinical Trials-03-01-2022
Volume: 31
Issue: 3
Applied Clinical Trials-02-01-2022
Volume: 31
Issue: 1/2
Applied Clinical Trials-12-01-2021
Volume: 30
Issue: 12
Applied Clinical Trials-11-01-2021
Volume: 30
Issue: 11
Applied Clinical Trials-10-01-2021
Volume: 30
Issue: 10
Applied Clinical Trials-09-01-2021
Volume: 30
Issue: 9
Applied Clinical Trials-08-01-2021
Volume: 30
Issue: 7/8
Applied Clinical Trials-06-01-2021
Volume: 30
Issue: 6
Applied Clinical Trials-05-01-2021
Volume: 30
Issue: 5
Applied Clinical Trials-04-01-2021
Volume: 30
Issue: 4
Applied Clinical Trials-03-01-2021
Volume: 30
Issue: 3
Applied Clinical Trials-02-01-2021
Volume: 30
Issue: 1/2
Applied Clinical Trials-12-01-2020
Volume: 29
Issue: 12
Applied Clinical Trials-11-01-2020
Volume: 29
Issue: 11
Applied Clinical Trials-10-01-2020
Volume: 29
Issue: 10
Applied Clinical Trials-09-01-2020
Volume: 29
Issue: 9
Applied Clinical Trials-08-01-2020
Volume: 29
Issue: 7/8
Applied Clinical Trials-06-01-2020
Volume: 29
Issue: 6
Applied Clinical Trials-05-01-2020
Volume: 29
Issue: 5
Applied Clinical Trials-04-01-2020
Volume: 29
Issue: 4
Applied Clinical Trials-03-01-2020
Volume: 29
Issue: 3
Applied Clinical Trials-02-01-2020
Volume: 29
Issue: 2
Applied Clinical Trials-12-01-2019
Volume: 28
Issue: 12
Applied Clinical Trials-11-01-2019
Volume: 28
Issue: 11
Applied Clinical Trials-10-01-2019
Volume: 28
Issue: 10
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
2
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
3
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5